Lawmakers "Don't Care" About Safety Concerns With Rx Imports - GSK
This article was originally published in The Pink Sheet Daily
Congress' push to pass legislation that would legalize drug importation shows that it has placed political matters ahead of safety concerns, GlaxoSmithKline said Sept. 14 at the Bear Stearns health care conference in New York.
You may also be interested in...
Senate Majority Leader Frist says he does not expect to fit Rx import language into the schedule during the session’s remaining days. The Senate Health Committee has no plans to markup a bill.
Outstanding safety concerns are the sole reason for not yet allowing reimportation from Canada, Bush says during Q&A session with voters. By making drug imports a question of resources, he opens the door to approving some version of the practice.
Sales reps are encouraged to advance GSK's agenda on importation directly to patients through community meetings. The company expressed optimism that the program could reach millions of U.S. citizens before the 2004 elections.